Association between oxygen consumption and nitric oxide production during the relaxation response

Medical Science Monitor

Volumn 12, Issue 1, 2006, Pages

  Dusek, Jeffery A ^a,b   Chang, Bei Hung ^a,c   Zaki, Jamil ^a   Lazar, Sara W ^d   Deykin, Aaron ^e   Stefano, George B ^f   Wohlhueter, Ann L ^a   Hibberd, Patricia L ^g   Benson, Herbert ^a,b  

^a Mind/Body Medical Institute   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f STATE UNIVERSITY OF NEW YORK   (United States)

^g TUFTS MEDICAL CENTER   (United States)

Author keywords

Fractional exhaled nitric oxide; Relaxation response; Stress; Volumetric oxygen consumption

Indexed keywords

NITRIC OXIDE; OXYGEN;

ADULT; ARTICLE; AUDIOVISUAL EQUIPMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; EXHALATION; FEMALE; HUMAN; MALE; MEASUREMENT; NORMAL HUMAN; OXYGEN CONSUMPTION; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RELAXATION TRAINING; SINGLE BLIND PROCEDURE;

ADULT; HUMANS; NITRIC OXIDE; OXYGEN CONSUMPTION; RELAXATION; RELAXATION TECHNIQUES; STATISTICS; TAPE RECORDING;

EID: 30944432558     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (100)

1. Benson H: The Relaxation Response: Its subjective and objective historical precedents and physiology. TINS, 1983; 6: 281-84
2. Wolsko PM et al: Use of mind-body medical therapies. J Gen Intern Med, 2004, 19(1): 43-50
3. Barnes PM et al: Complementary and alternative medicine use among adults: United States, 2002. Adv Data, 2004; (343): 1-19
4. Benson H, Beary JF, Carol MP: The relaxation response. Psychiatry, 1974, 37(1): 37-46
5. Benson H: The relaxation response. William Morrow, New York, 1975
6. Wallace RK, Benson H, Wilson AF: A wakeful hypometabolic physiologic state. Am J Physiol, 1971; 221(3): 795-99
7. Cannon W: Emergency function of the adrenal medulla in pain and the major emotions. Am J Physiol, 1914; 33: 356
8. Selye H: The Stress of Life. McGraw-Hill, New York, 1956
9. Beary JF, Benson H: A simple psychophysiologic technique which elicits the hypometabolic changes of the relaxation response. Psychosom Med, 1974; 36(2): 115-20
10. 2 elimination during a wakeful hypometabolic state. J Human Stress, 1975; 1(1): 37-44
11. Fenwick PB et al: Metabolic and EEG changes during transcendental meditation: an explanation. Biol Psychol, 1977; 5(2): 101-18
12. Warrenburg S et al: A comparison of somatic relaxation and EEG activity in classical progressive relaxation and transcendental meditation. J Behav Med, 1980; 3(1): 73-93
13. Kesterson J, Clinch NF: Metabolic rate, respiratory exchange ratio, and apneas during meditation. Am J Physiol, 1989; 256(3 Pt 2): R632-38
14. Sudsuang R, Chentanez V, Veluvan K: Effect of Buddhist meditation on serum cortisol and total protein levels, blood pressure, pulse rate, lung volume and reaction time. Physiol Behav, 1991, 50(3): 543-48
15. Benson H et al: Decreased blood-pressure in pharmacologically treated hypertensive patients who regularly elicited the relaxation response. Lancet, 1974, 1(7852): 289-91
16. Benson H et al: Decreased blood pressure in borderline hypertensive subjects who practiced meditation. J Chronic Dis, 1974; 27(3): 163-69
17. Peters RK, Benson H, Peters JM: Daily relaxation response breaks in a working population: II. Effects on blood pressure. Am J Public Health, 1977; 67(10): 954-59
18. Barnes VA et al: Impact of meditation on resting and ambulatory blood pressure and heart rate in youth. Psychosom Med, 2004; 66(6): 909-14
19. Hoffman JW et al: Reduced sympathetic nervous system responsivity associated with the relaxation response. Science, 1982; 215(4529): 190-92
20. Jacobs GD, Benson H, Friedman R: Topographic EEG mapping of the relaxation response. Biofeedback Self Regul, 1996; 21(2): 121-29
21. Takahashi T et al: Changes in EEG and autonomic nervous activity during meditation and their association with personality traits. Int J Psychophysiol, 2005; 55(2): 199-207
22. Peng CK et al: Exaggerated heart rate oscillations during two meditation techniques. Int J Cardiol, 1999; 70(2): 101-7
23. Peng CK et al: Heart rate dynamics during three forms of meditation. Int J Cardiol, 2004; 95(1): 19-27
24. Lazar SW et al: Functional brain mapping of the relaxation response and meditation. Neuroreport, 2000; 11(7): 1581-85
25. Lazar SW et al: Meditation Experience is Associated with increased Cortical Thickness. Neuroreport, 2005; 16(17): 1893-97
26. Sternberg E, Gold PW: The mind-body interaction in disease. Scientific Amer, 1997; 7(1): 8-15
27. Benson H, Alexander S, Feldman CL: Decreased premature ventricular contractions through use of the relaxation response in patients with stable ischaemic heart-disease. Lancet, 1975; 2(7931): 380-82
28. Leserman J et al: Nonpharmacologic intervention for hypertension: Long term follow up. J Cardiopulmonary Rehabil, 1989; 9: 316-24
29. Stuart EM et al: Nonpharmacologic treatment of hypertension: a multiple-risk-factor approach. J Cardiovasc Nurs, 1987; 1(4): 1-14
30. Blumenthal J et al: Stress management and exercise training in cardiac patients with myocardial ischemia: effects on prognosis and evaluation of mechanisms. Archives of Internal Medicine, 1997; 157: 2213-23
31. Chang BH et al: Relaxation response for Veterans Affairs patients with congestive heart failure: results from a qualitative study within a clinical trial. Prev Cardiol, 2004; 7(2): 64-70
32. Chang BH et al: A relaxation response randomized trial on patients with chronic heart failure. J Cardiopulm Rehabil, 2005; 25(3): 149-57
33. van Dixhoorn J, White A: Relaxation therapy for rehabilitation and prevention in ischaemic heart disease: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil, 2005; 12(3): 193-202
34. Benson H et al: Treatment of anxiety: a comparison of the usefulness of self-hypnosis and a meditational relaxation technique. An overview. Psychother Psychosom, 1978; 30(3-4): 229-42
35. Kabat-Zinn J et al: Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. Am J Psychiatry, 1992; 149(7): 936-43
36. Miller J, Fletcher KE, Kabat-Zinn J: Three year follow-up and clinical implications of a mindfulness meditation based stress reduction intervention in the treatment of anxiety disorders. Gen Hosp Psychiatry, 1995; 17: 192-200
37. Nakao M et al: Anxiety is a good indicator for somatic symptom reduction through behavioral medicine intervention in a mind/body medicine clinic. Psychother Psychosom, 2001; 70(1): 50-57
38. Carrington P et al: The use of meditation - relaxation techniques for the management of stress in a working population. J Occup Med, 1980; 22(4): 221-31
39. Hellman CJ et al: A study of the effectiveness of two group behavioral medicine interventions for patients with psychosomatic complaints. Behav Med, 1990; 16(4): 165-73
40. Nakao M et al: Somatization and symptom reduction through a behavioral medicine intervention in a mind/body medicine clinic. Behav Med, 2001; 26(4): 169-76
41. Jacobs GD, Friedman R: Home-based central nervous system assessment of multifactor behavioral intervention for chronic sleep-onset insomnia. Behav Ther, 1993; 24: 159-74
42. Jacobs GD et al: Multifactor behavioral treatment of chronic sleep-onset insomnia using stimulus control and the relaxation response. A preliminary study. Behav Modif, 1993; 17(4): 498-509
43. Morin C, Culbert J, Schwartz S: Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry, 1994; 151: 1172-80
44. Benson H, Klemchuk HP, Graham JR: The usefulness of the relaxation response in the therapy of headache. Headache, 1974; 14(1): 49-52
45. Benson H, Malvea BP, Graham JR: Physiologic correlates of meditation and their clinical effects in headache: an ongoing investigation. Headache, 1973; 13(1): 23-24
46. Fentress DW et al: Biofeedback and relaxation-response training in the treatment of pediatric migraine. Dev Med Child Neurol, 1986; 28(2): 139-46
47. Astin JA: Mind-body therapies for the management of pain. Clin J Pain, 2004, 20(1): 27-32
48. Caudill M et al: Decreased clinic utilization by chronic pain patients after behavioral medicine intervention. Pain, 1991; 45(3): 334-35
49. Luskin FM et al: A review of mind/body therapies in the treatment of musculoskeletal disorders with implications for the elderly. Altern Ther Health Med, 2000, 6(2): 46-56
50. Astin JA et al: Psychological Interventions for Rheumatoid Arthritis: A Meta-Analysis of Randomized controlled trials. Arthritis and Rhuematism, 2002; 47(3): 291-302
51. Broderick JE: Mind-body medicine in rheumatologic disease. Rheum Dis Clin North Am, 2000; 26(1): 161-76, xi
52. Astin JA et al: The ef. cacy of mindfulness meditation plus Qigong movement therapy in the treatment of fibromyalgia: a randomized controlled trial. J Rheumatol, 2003; 30(10): 2257-62
53. Goodale IL, Domar AD, Benson H: Alleviation of premenstrual syndrome symptoms with the relaxation response. Obstet Gynecol, 1990; 75(4): 649-55
54. Domar AD, Seibel MM, Benson H: The mind/body program for infertility: a new behavioral treatment approach for women with infertility. Fertil Steril, 1990; 53(2): 246-49
55. Domar AD et al: Psychological improvement in infertile women after behavioral treatment: a replication. Fertil Steril, 1992; 58(1): 144-47
56. Dreher H: Mind-body Interventions for surgery: evidence and exigency. Adv Mind-Body Med, 1998; 14: 207-22
57. Leserman J et al: The efficacy of the relaxation response in preparing for cardiac surgery. Behav Med, 1989; 15(3): 111-17
58. Wientjes KA: Mind-body techniques in wound healing. Ostomy Wound Manage, 2002; 48(11): 62-67
59. Lang E et al: Adjunctive non-pharmacological analgesia for invasive medical procedures: a randomized trial. Lancet, 2000; 355: 1486-90
60. Mandle CL et al: Relaxation response in femoral angiography. Radiology, 1990; 174(3 Pt 1): 737-79
61. Burish T, Lyles J: Effectiveness of relaxation training in reducing nausea and vomiting induced by cancer chemotherapy. J Behav Med, 1981; 4: 65-78
62. Spiegel D, Moore R: Imagery and Hypnosis in the treatment of cancer patients. Oncology, 1997, 11 :1179-95
63. Syrjala K, Cummings C, Donaldson G: Hypnosis or cognitive behavioral training for the reduction of pain and nausea during cancer treatment: a controlled clinical trial. Pain, 1992; 48: 137-46
64. Syrjala K, Donaldson G, Davis M: Relaxation and Imagery and cognitive-behavioral training reduce pain during cancer treatment: a controlled clinical trial. Pain, 1995; 63: 189-98
65. Vasterling J et al: Cognitive distraction and relaxation training for the control of side effects due to cancer chemotherapy. J Behav Med, 1993; 16: 65-80
66. Bredt DS Snyder SH: Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem, 1994; 63: 175-95
67. Rivier C: Role of nitric oxide and carbon monoxide in modulating the activity of the rodent hypothalamic-pituitary-adrenal axis. Front Horm Res, 2002; 29: 15-49
68. Ignarro LJ et al: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci A, 1987; 84(24): 9265-69
69. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med, 1993, 329(27): 2002-12
70. Vita JA: Nitric oxide-dependent vasodilation in human subjects. Methods Enzymol, 2002, 359: 186-200
71. Mitchell BM, Webb RC: Impaired vasodilation and nitric oxide synthase activity in glucocorticoid-induced hypertension. Biol Res Nurs, 2002; 4(1): 16-21
72. Ferrari AU et al: Nitric oxide-dependent vasodilation and the regulation of arterial blood pressure. J Cardiovasc Pharmacol, 2001, 38(Suppl.2): S19-22
73. Stefano GB et al: The placebo effect and relaxation response: neural processes and their coupling to constitutive nitric oxide. Brain Res Brain Res Rev, 2001; 35(1): 1-19
74. Toda N, Okamura T: The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol Rev, 2003; 55(2): 271-324
75. Sartori C, Lepori M, Scherrer U: Interaction between nitric oxide and the cholinergic and sympathetic nervous system in cardiovascular control in humans. Pharmacol Ther, 2005, 106(2): 209-20
76. Archer S: Measurement of nitric oxide in biological models. Faseb J, 1993; 7(2): 349-60
77. Gustafsson LE et al: Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun, 1991; 181(2): 852-57
78. Schmidt HH, Walter U: NO at work. Cell, 1994, 78(6): 919-25
79. ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005. Am J Respir Crit Care Med, 2005; 171(8): 912-30
80. Kato M et al: Amlodipine increases nitric oxide production in exhaled air during exercise in patients with essential hypertension. Am J Hypertens, 2004; 17(9): 729-33
81. Napoli C, Ignarro LJ: Nitric oxide-releasing drugs. Annu Rev Pharmacol Toxicol, 2003. 43: 97-123
82. Benson H et al: Three case reports of the metabolic and electroencephalographic changes during advanced Buddhist meditative techniques. Behav Med, 1990; 16: 90-95
83. Negrao AB et al: Individual reactivity and physiology of the stress response. Biomed Pharmacother, 2000; 54(3): 122-28
84. Rohleder N, Wolf JM, Kirschbaum C: Glucocorticoid sensitivity in humans-interindividual differences and acute stress effects. Stress, 2003; 6(3): 207-22
85. Olson T, Tracy JE, Dengel DR: Validity of a low-flow pneumotach and portable metabolic system for measurement of basal metabolic rate. Med Sci Sports Exer, 2003; 35: S143
86. rd ed., Wiley, New York, 1998
87. Leone AM et al: Nitric oxide is present in exhaled breath in humans: direct GC-MS confirmation. Biochem Biophys Res Commun, 1994; 201(2): 883-87
88. Singh A et al: Differential hypothalamic-pituitary-adrenal axis reactivity to psychological and physical stress. J Clin Endocrinol Metab, 1999; 84(6): 1944-48
89. Petrides JS et al: Marked differences in functioning of the hypothalamic-pituitary-adrenal axis between groups of men. J Appl Physiol, 1997; 82(6): 1979-88
90. Gallucci WT et al: Sex differences in sensitivity of the hypothalamic-pituitary-adrenal axis. Health Psychol, 1993; 12(5): 420-25
91. Gryglewski RJ, Palmer RM, Moncada S: Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature, 1986; 320(6061): 454-56
92. Liu J, Thomas PS: Exhaled breath condensate as a method of sampling airway nitric oxide and other markers of inflammation. Med Sci Monit, 2005; 11(8): MT53-MT62
93. Leone AM et al: A rapid and simple method for the measurement of nitrite and nitrate in plasma by high performance capillary electrophoresis. Biochem Biophys Res Commun, 1994; 200(2): 951-57
94. Pietropaoli AP et al: Exhaled nitric oxide does not provide a marker of vascular endothelial function in healthy humans. Am J Respir Crit Care Med, 2000; 161(6): 2113-14
95. Malmstrom RE et al: Endogenous nitric oxide release by vasoactive drugs monitored in exhaled air. Am J Respir Crit Care Med, 2003; 168(1): 114-20
96. Sartori C et al: Exhaled nitric oxide does not provide a marker of vascular endothelial function in healthy humans. Am J Respir Crit Care Med, 1999, 160(3): 879-82
97. Moncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev, 1991, 43(2): 109-42
98. Kharitonov SA et al: Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle. Br Heart J, 1994; 72(3): 243-45
99. Rivier C: Role of nitric oxide and carbon monoxide in modulating the ACTH response to immune and nonimmune signals. Neuroimmunomodulation, 1998; 5(3-4): 203-13
100. Haddad JJ, Saade NE, Sa. eh-Garabedian B: Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary- adrenal revolving axis. J Neuroimmunol, 2002; 133(1-2): 1-19